TLR4 and gram-negative bacterial infections: Based on the results presented here, the TLR4-interacting SPA4 peptide may offer a novel host-targeted approach for the treatment of antibiotic-resistant, Gram-negative bacterial infections that are accompanied by inflammation and tissue injury.